Cargando…

Reduced Adenosine Uptake and Its Contribution to Signaling that Mediates Profibrotic Activation in Renal Tubular Epithelial Cells: Implication in Diabetic Nephropathy

Altered nucleoside levels may be linked to pathogenic signaling through adenosine receptors. We hypothesized that adenosine dysregulation contributes to fibrosis in diabetic kidney disease. Our findings indicate that high glucose levels and experimental diabetes decreased uptake activity through the...

Descripción completa

Detalles Bibliográficos
Autores principales: Kretschmar, Catalina, Oyarzún, Carlos, Villablanca, Cristopher, Jaramillo, Catherinne, Alarcón, Sebastián, Perez, Gustavo, Díaz-Encarnación, Montserrat M., Pastor-Anglada, Marçal, Garrido, Wallys, Quezada, Claudia, San Martín, Rody
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4726618/
https://www.ncbi.nlm.nih.gov/pubmed/26808537
http://dx.doi.org/10.1371/journal.pone.0147430
Descripción
Sumario:Altered nucleoside levels may be linked to pathogenic signaling through adenosine receptors. We hypothesized that adenosine dysregulation contributes to fibrosis in diabetic kidney disease. Our findings indicate that high glucose levels and experimental diabetes decreased uptake activity through the equilibrative nucleoside transporter 1 (ENT1) in proximal tubule cells. In addition, a correlation between increased plasma content of adenosine and a marker of renal fibrosis in diabetic rats was evidenced. At the cellular level, exposure of HK2 cells to high glucose, TGF-β and the general adenosine receptor agonist NECA, induced the expression of profibrotic cell activation markers α-SMA and fibronectin. These effects can be avoided by using a selective antagonist of the adenosine A(3) receptor subtype in vitro. Furthermore, induction of fibrosis marker α-SMA was prevented by the A(3) receptor antagonist in diabetic rat kidneys. In conclusion, we evidenced the contribution of purinergic signaling to renal fibrosis in experimental diabetic nephropathy.